Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia

Yonsei Medical Journal

Volumn 49, Issue 1, 2008, Pages 151-154

  Lee, Hea Yong ^a   Im, Sung Il ^a   Kang, Myoung Hee ^a   Kim, Kwang Min ^a   Kim, Seok Hyun ^a   Kim, Hun Gu ^a,b   Kang, Jung Hun ^a,b   Lee, Gyeong Won ^a,b  

^a Gyeongsang National University   (South Korea)

^b Gyeongnam Regional Cardiocerebrovascular Disease Center   (South Korea)

Author keywords

Acute lymphoblastic leukemia; Cytosine arabinoside; Intrathecal chemotherapy; Methotrexate

Indexed keywords

ASPARAGINASE; CD19 ANTIGEN; CD22 ANTIGEN; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; GADOLINIUM; HLA DR ANTIGEN; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AREFLEXIA; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CYTOPENIA; ELECTROMYOGRAM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LUMBAR SPINE; MAINTENANCE THERAPY; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; SKIN BRUISING; SPINAL CORD ATROPHY; SPINAL CORD DISEASE; THROMBOCYTE COUNT; TREATMENT DURATION; URINE RETENTION; VENTRAL ROOT; WEAKNESS;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 41949088548     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.1.151     Document Type: Article

References (24)

1. Bleyer WA, Poplack DG. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 1985;12:131-48.
2. Bay A, Oner AF, Etlik O, Yilmaz C, Caksen, H. Myelopathy due to intrathecal chemotherapy: report of six cases. J Pediatr Hematol Oncol 2005;27:270-2.
3. Skullerud K, Halvorsen K. Fncephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia. Cancer 1978;42:1211-5.
4. Boogerd W, Moffie D, Smets LA. Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis. Cancer 1990;65:452-7.
5. Breuer AC, Pitman SW, Dawson DM, Schoene WC. Paraparesis following intrathecal cytosine arabinobide: a case report with neuropathologic findings. Cancer 1977;40:2817-22.
6. Clark AW, Cohen SR, Nissenblatt MJ, Wilson SK. Paraplegia following intrathecal chemotherapy: neuro-pathologic findings and elevation of myelin basic protein. Cancer 1982;50:42-7
7. Dunton SF, Nitschke R, Spruce WE, Bodensteiner J, Krous HF. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group Study. Cancer 1986;57:1083-8.
8. Gagliano RG, Costanzi JJ. Paraplegia following intrathecal methotrexate: report of a case and review of the literatture. Cancer 1976;37:1663-8.
9. Grisold W, Lutz D, Wolf D. Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature. Acta Neuropathol 1980; 49:231-5.
10. Luddy RE, Gilman PA. Paraplegia following intrathecal methotrexate. J Pediatr 1973;83:988-92.
11. Mena H, Garcia JH, Velandia F. Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy. Cancer 1981;48:1724-37.
12. Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain-Barré syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol 1987;39:75-6.
13. Ojeda VJ. Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review. Cancer 1984;53:1115-23.
14. Resar LM, Phillips PC, Kastan MB, Leventhal BG, Bowman PW, Civin CI. Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type. Cancer 1993;71:117-23.
15. Saiki JH, Thompson S, Smith F, Atkinson R. Paraplegia following intrathecal chemotherapy. Cancer 1972;29: 370-4.
16. Werner RA. Paraplegia and quadriplegia after intrathecal chemotherapy. Arch Phys Med Rehabil 1988;69: 1054-6.
17. Wolff L, Zighelboim J, Gale RP. Paraplegia following intrathecal cytosine arabinoside. Cancer 1979;43:83-5.
18. Koh S, Nelson MD Jr, Kovanlikaya A, Chen LS. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment. Pediatr Neurol 1999;21:576-8.
19. Gilbert MR, Harding BL, Grossman SA. Methotrexate neurotoxicity: In vitro studies using cerebellar explants from rats. Cancer 1989;49:2502-5.
20. Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, et al. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer 1994;74:3034-41.
21. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973;289:770-3.
22. Sherman PM, Belden CJ, Nelson DA. Magnetic resonance imaging findings in a case of cytarabine-induced myelopathy. Mil Med 2002;167:457-60.
23. Shore T, Barnett MJ, Phillips GL. Sudden neurologic death after intrathecal methotrexate. Med Pediatr Oncol 1990;18:159-61.
24. von der Weid NX, de Crousaz H, Beck D, Deonna T, Miklossy J, Janzer RC. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. Med Pediatr Oncol 1991;19:192-8.